The drugmaker is pulling back on some of its research programs and laying off workers after overestimating pandemic-product sales.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles
The drugmaker is pulling back on some of its research programs and laying off workers after overestimating pandemic-product sales.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles